Value for Money
The Global Fund’s Value for Money technical brief provides a framework to guide investment decisions and maximize health impact, particularly for the populations most affected by disease, while operating within constrained resources.
Value for Money is about making strategic choices: identifying which interventions are most effective in addressing specific health challenges; determining where and to whom these interventions should be delivered to achieve the greatest impact; and ensuring they are implemented efficiently to minimize waste, duplication, and unnecessary costs.
By promoting efficiency, effectiveness, equity and accountability, the Value for Money approach strengthens the sustainability of health and community systems and supports continued access to essential services.
Strong procurement systems and strategic sourcing also play a key role in delivering value for money. Through pooled purchasing and global partnerships, Global Fund supports access to quality medicines, diagnostics, and health products at competitive prices. This approach reduces costs while improving availability and reliability across health programs. The Global Fund also supports the introduction of innovations such as Lenacapavir.
Transparency and accountability are central to the Global Fund’s commitment to value for money, including robust financial oversight, independent audits, and performance monitoring.
To support CCMs, PRs and partners, the Global Fund has issued the following documents:
- Enabling Impact Guidance on Maximizing Value for Money [ download in English | Español | Français ]
- Value for Money Technical Brief [ download in English | Español | Français ]
The documents should be read in conjunction with the following guidance:
- RSSH prioritization [ download in English | Español | Français ]
- Advancing Integration [ download in English | Español | Français ]
- Strengthening Sustainability [ download in English | Español | Français ]
- Transition and Co-financing [ download in English ]